Second, the association was non-specific: in negative control analyses, a similar increased risk of two other sun-exposure-related outcomes (basal cell carcinoma and solar keratosis) was observed among PDE5 inhibitor users. This evidence concerns the gene PDE5A and basal cell carcinoma.